List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 236 studies with search of: Open Studies | "Prednisone"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Sunitinib Plus Prednisone In Patients With Metastatic Hormone-Refractory Prostate Cancer After Failure Of Docetaxel Chemotherapy
Condition: Prostatic Neoplasms
Interventions: Drug: Prednisone;   Drug: sunitinib;   Drug: Placebo
2 Not yet recruiting Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis
Condition: Focal Segmental Glomerulosclerosis
Interventions: Drug: prednisone, FK506, MMF;   Drug: prednisone
3 Recruiting Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma
Condition: Mantle Cell Lymphoma
Interventions: Drug: Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone;   Drug: Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone
4 Recruiting Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)
Condition: Prostatic Neoplasms
Interventions: Drug: CP-751,871;   Drug: docetaxel;   Drug: prednisone
5 Not yet recruiting The Use of Oral Steroids in the Treatment of Cellulitis
Conditions: Cellulitis;   Erysipelas
Intervention: Drug: Prednisone
6 Recruiting Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: Prednisone - Azathioprine
7 Recruiting A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: PF-04171327 10 mg;   Other: Prednisone Placebo;   Drug: PF-04171327 25 mg;   Drug: Prednisone 5 mg;   Other: Placebo for PF-04171327;   Other: Placebo
8 Recruiting Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-Resistant Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Docetaxel;   Drug: Prednisone;   Drug: 177Lu-J591
9 Not yet recruiting Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone
Condition: Pemphigus Vulgaris
Interventions: Drug: Azathioprine;   Drug: Prednisone;   Drug: Placebo
10 Not yet recruiting Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Condition: Ocular Myasthenia Gravis
Interventions: Drug: Prednisone;   Drug: Placebo
11 Recruiting Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Lenalidomide and low-dose dexamethasone;   Drug: Lenalidomide plus low-dose dexamethasone given for 18 four-week cycles;   Drug: Melphalan, Prednisone and Thalidomide
12 Recruiting The Effect of Preoperative Oral Prednisone on the Operative Field During Nasal Polypectomy: A Pilot Study
Condition: Nasal Polyps
Interventions: Drug: Prednisone;   Drug: Placebo comparator
13 Recruiting Study Using IMC-A12 or IMC-1121B Plus Mitoxantrone and Prednisone in Metastatic Androgen-Independent Prostate Cancer, Following Disease Progression on Docetaxel-Based Chemotherapy
Condition: Prostate Cancer
Interventions: Biological: IMC-A12;   Drug: Mitoxantrone;   Drug: Prednisone;   Biological: IMC-1121B
14 Recruiting Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy
Condition: Myasthenia Gravis
Interventions: Procedure: thymectomy;   Drug: prednisone
15 Not yet recruiting Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in People With Idiopathic Pulmonary Fibrosis
Condition: Pulmonary Fibrosis
Interventions: Drug: Prednisone;   Drug: Azathioprine;   Drug: N-acetylcysteine (NAC);   Drug: Placebo
16 Recruiting Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Docetaxel;   Drug: Prednisone;   Drug: SU011248
17 Recruiting Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma
Condition: Relapsed Follicular Lymphoma
Interventions: Drug: VELCADE, rituximab, cyclophosphamide, prednisone, and Doxorubicin;   Drug: VELCADE, rituximab, cyclophosphamide, and prednisone
18 Recruiting Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)
Conditions: Hodgkin's Disease;   Lymphoma
Intervention: Drug: rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim
19 Recruiting Prednisone for Heart Failure Patients With Hyperuricemia
Conditions: Heart Failure;   Hyperuricemia
Interventions: Drug: prednisone;   Drug: allopurinol
20 Recruiting Test Predicting Adrenal Insufficiency in Volunteers Under Prednisone Treatment
Condition: Adrenal Gland Hypofunction
Interventions: Procedure: adrenal insufficiency testing;   Drug: prednisone

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services